Drugs / Epaxal Berna
last change Mar 2013 re-read 3 minutes ago

Epaxal Berna

Vaccine

Developed for
hepatitis A virus infection
Investigated by
Asan Medical Center

Trials 1

20112012201320142015201620172018201920202021202220232024202520262027
PhaseRegistry idDatesIndicationSponsorStatusOutcome
Phase 4 NCT01341808 Apr 2011 → Feb 2013 Crohn disease, hepatitis A virus infection, ulcerative colitis Asan Medical Center Completed No outcome recorded

Evidence & citations 2 cited values

Every value below carries the sentence it was read from. 1 source stands behind the page.

FieldValueCited text
Known as Epaxal Berna ClinicalTrials.gov intervention name — accepted as the source's own label NCT01341808 ↗
Modality Vaccine “Epaxal Berna (virosomal hepatitis A vaccine)” NCT01341808 ↗